-

Eighteenth edition of Fujio Cup Quiz won by Kasturba Medical College, India in the NCRM NICHE 2023 international stem cell meeting.

Edogawa NICHE Prize award ceremony honoring Dr Craig Venter to be held in Toronto, Canada.

TOKYO--(BUSINESS WIRE)--Harshavardhan Sai Sadineni and Srived Meda of Kasturba Medical College, Manipal, India, won the XVIII Fujio Cup Quiz (FCQ) on Stem cells and Regenerative medicine (RM) in the NCRM NICHE 2023; Sri Ramachandra Institute for Higher Education and Research, India and Institut Teknologi Bandung, Indonesia emerged as runners and joined the team of FCQ elites, a privilege bestowed on those who reach the final stage of the multi-level international contest including a quiz in RM, thereby qualifying to nominate the candidate(s) to Edogawa NICHE Prize, instituted in 2018. The Edogawa NICHE Prize awardee of 2020, Dr John Craig Venter will deliver his lecture at the UHN Ajmera Transplant Center, on the 25th October 2023, in conjunction with the Training Program in Regenerative Medicine (TPRM) at the University of Toronto, co-hosted by German Society for Stem Cell Research (GSZ).

Dr. Craig Venter to deliver Edogawa NICHE Prize Lecture in Toronto on Oct. 25, 2023; Two more scholars of Kasturba Medical College, India, winners of 18th Fujio Cup Quiz join the FCQ Elites club, who are eligible to nominate Edogawa NICHE Prize awardees

Share

FCQ is an active knowledge gaining event in RM started in 2006 in India, as a part of NCRM NICHE, the inaugural anniversary commemorative event of Nichi-in Centre for Regenerative medicine (NCRM), held every October, conducted in Tokyo 2017~2019, and now virtually. NCRM NICHE has triggered novel ideas and collaborations yielding cutting edge solutions in cell therapies such as the Buccal epithelium Expanded and Encapsulated in Scaffold-Hybrid Approach to Urethral Stricture (BEES HAUS) with clinical studies of safety & efficacy and preclinical evidence, tissue engineering technologies for transplant suitable human chondrocytes for cartilage repair with age reversal in vitro, optimized solutions for transport of cells and tissues for processing between hospitals and cell processing facilities. Through a global inter-disciplinary networking, disease modifying adjunct solutions developed for unmet needs viz., Duchenne muscular dystrophy (DMD), multiple sclerosis (MS), Autism spectrum disorders (ASD), and Parkinson’s disease (PD), were presented in the Inter-disciplinary Conclave (IDC).

Prof. Dr. Mihai G. Netea, Radboud University Medical Center, Netherlands, talked on Trained immunity and innate host defense, Dr Shojiro Katoh, President, Edogawa Hospital, on Novel tissue engineering technology enhancing cell therapies for cartilage repair, Mr. Yasutoshi Nishikawa, on Biomaterials for bone reconstruction and Dr Dedeepiya Devaprasad, on Gut microbiome, Gut-brain-axis & Brain health, moderated by Prof. Dr. Jurgen Hescheler, University of Cologne, Germany.

NCRM with cell biology and biomaterial laboratories, in collaboration with academic and industry partners in Japan are researching on the basic origin of diseases at cellular level taking cues from immune system evolution across phylogeny, in vitro culture systems and in vivo biological responders.

Contacts

Samuel JK Abraham
info@gncorporation.com

GN Corporation Co Ltd


Release Summary
Kasturba medical college, XVIII Fujio cup quiz winners along with finalists become FCQ elites, an eligibility to nominate Edogawa NICHE Prize awardees

Contacts

Samuel JK Abraham
info@gncorporation.com

Social Media Profiles
More News From GN Corporation Co Ltd

Astronauts’ Health During Space Missions: Nichi BRITE and Neu REFIX Beta Glucans Could Benefit by Neutrophil-to-Lymphocyte Ratio, IL-6 Control, the Immune Biomarkers of Aging and Longevity

TOKYO--(BUSINESS WIRE)--Neutrophil to Lymphocyte ratio (NLR) is a critical biomarker of health of astronauts during space mission, and that of aging related illnesses, inflammaging, longevity and cancer prognosis. Oral consumption of AFO-202 strain of Aureobasidium pullulans produced Nichi BRITE and N-163 strain produced Neu REFIX together in pre-clinical and clinical studies having safely and beneficially modified NLR, are considered holding potential to help maintain astronauts health during...

Neu-REFIX Beta glucan receives rare pediatric disease and orphan drug designations from the US FDA for treatment of Duchenne Muscular Dystrophy

TOKYO--(BUSINESS WIRE)--Neu refix granted orphan disease designation (ODD) & rare pediatric disease designation (RPDD) by US FDA for treatment of Duchenne muscular dystrophy...

Nichi BRITE Beta glucan as an onco-nutrition supplement in pancreatic cancer; Encouraging clinical results reported by Chikamori Hospital, Japan.

TOKYO--(BUSINESS WIRE)--Nichi BRITE beta glucans benefitted pancreatic cancer patients as an onco-nutrition supplement in a clinical study by Chikamori hospital, Kochi, Japan...
Back to Newsroom